Heart & Lung: The Journal of Acute and Critical Care
Volume 35, Issue 3 , Pages 207-211 , May 2006

Pacemaker-induced Staphylococcus aureus mitral valve acute bacterial endocarditis complicated by persistent bacteremia from a coronary stent: Cure with prolonged/high-dose daptomycin without toxicity

  • Burke A. Cunha, MD

      Affiliations

    • Infectious Disease Division, Winthrop-University Hospital, Mineola, New York
    • State University of New York School of Medicine, Stony Brook, New York
    • Corresponding Author InformationReprint requests: Burke A. Cunha, MD, Chief, Infectious Disease Division, Winthrop-University Hospital, Mineola, New York 11501.
    • ,
  • Lawrence E. Eisenstein, MD

      Affiliations

    • Infectious Disease Division, Winthrop-University Hospital, Mineola, New York
    • State University of New York School of Medicine, Stony Brook, New York
    • ,
  • Naveed S. Hamid, MD

      Affiliations

    • Infectious Disease Division, Winthrop-University Hospital, Mineola, New York
    • State University of New York School of Medicine, Stony Brook, New York

References 

  1. In:  Weinstein L ,  Brusch J editor. Infective Endocarditis . Oxford, UK: Oxford University Press; 1996;
  2. Cunha BA , Gill MV , Lazar J . Acute infective endocarditis . Infect Dis Clin North Am . 1996;10:811–834
  3. Chambers HF , Korzeniowski OM , Sande MA . Staphylococcus aureus Endocarditis (clinical manifestations in addicts and non-addicts) . Medicine . 1983;3:170–176
  4. Giamarellou H . Nosocomial cardiac infections . J Hosp Infect . 2002;50:91–105
  5. Gilleece A , Fenelon L . Nosocomial infective endocarditis . J Hosp Infect . 2000;46:83–88
  6. Brusch JL . Nosocomial infective endocarditis . Infect Dis Pract . 2003;27:247–250
  7. Haddad SH , Arabi YM , Memish ZA , Al-Shimemeri AA . Nosocomial infective endocarditis in critically ill patients (a report of three cases and review of the literature) . Int J Infect Dis . 2004;8:210–216
  8. Waldwogel F . Pacemaker infections . In:  Bisno AL ,  Waldvogel FA editor. Infections Associated With Indwelling Mechanical Devices . 2nd ed.. Washington, DC: ASM Press; 1994;p. 251–258
  9. Klug D , Lacroix D , Savoye C , Goullard L , Grandmougin D , Hennequin JL , et al.   Systemic infection related to endocarditis on pacemaker leads. Clinical presentation and management . Circulation . 1997;95:2098–2107
  10. Lewis AB , Hayes DH , Holmes DR , et al.   Update on infections involving permanent pacemakers (characterization and management) . J Thorac Cardiovasc Surg . 1985;89:758–763
  11. Cacoub P , Leprince P , Nataf P , et al.   Pacemaker infective endocarditis . Am J Cardiol . 1998;82:480–484
  12. Arber N , Pras E , Copperman Y , et al.   Pacemaker endocarditis. Report of 44 cases and review of the literature . Medicine . 1994;73:299–305
  13. Camus C , Leport C , Raffi F , et al.   Sustained bacteremia in 26 patients with a permanent endocardial pacemaker (assessment of wire removal) . Clin Infect Dis . 1993;17:46–55
  14. Spinler SA , Navarskas JJ , Foote EF , et al.   Clinical presentation and analysis of risk factors for infectious complications of implantable cardioverter-defibrillator implantations at a university medical center . Clin Infect Dis . 1998;26:1111–1116
  15. Sullenberger AL , Avedissian LS , Kent SM . Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia . J Heart Valve Dis . 2005;14:23–28
  16. Leroy O , Martin E , Prat A , et al.   Fatal infection of coronary stent implantation . Cathet Cardiovasc Diagn . 1996;39:168–170
  17. James E , Broadhurst P , Simpson A , Das S . Bacteraemia complicating coronary artery stenting . J Hosp Infect . 1998;38:154–155
  18. Rensing BJ , van Geuns RJ , Janssen M , et al.   Stentocarditis . Circulation . 2000;101:E188–E190
  19. Dieter RS . Coronary artery stent infection . Clin Cardiol . 2000;23:808–810
  20. Culver DA , Chua J , Rehm SJ , et al.   Arterial infection and Staphylococcus aureus bacteremia after transfemoral cannulation for percutaneous carotid angioplasty and stenting . J Vasc Surg . 2002;35:576–579
  21. Liu JC , Cziperle DJ , Kleinman B , Loeb H . Coronary abscess (a complication of stenting) . Cathet Cardiovasc Interv . 2003;58:72
  22. Antonios VS , Baddour LM . Intra-arterial device infections . Curr Infect Dis Rep . 2004;6:263–269
  23. Hoffman M , Baruch R , Kaplan E , et al.   Coronary stent bacterial infection with multiple organ septic emboli . Eur J Intern Med . 2005;16:123–125
  24. Cunha BA , Ortega A . Antibiotic failure . Med Clin North Am . 1995;79:663–672
  25. Cunha BA . Persistent Staphylococcus aureus bacteremia (a clinical approach) . Infect Dis Pract . 2005;29:444–446
  26. Jeu L , Fung HB . Daptomycin (a cyclic lipopeptide antimicrobial agent) . Clin Ther . 2004;26:1728–1757
  27. Pryka RD , Novak RM , Wagner DK , Rodvold KA . Clinical pharmacokinetics of daptomycin . DICP . 1990;24:255–256
  28. Safdar N , Andes D , Craig WA . In vivo pharmacodynamic activity of daptomycin . Antimicrob Agents Chemother . 2004;48:63–68
  29. Dvorchik BH , Brazier D , DeBruin MF , Arbeit RD . Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects . Antimicrob Agents Chemother . 2003;47:1318–1323
  30. Dvorchik B , Arbeit RD , Chung J , et al.   Population pharmacokinetics of daptomycin . Antimicrob Agents Chemother . 2004;48:2799–2807
  31. Cunha BA , Hamid HS , Kessler H , Parchuri S . Daptomycin cure after Cefazolin treatment failure of Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line . Heart Lung . 2005;34:442–447
  32. Cunha BA . Antibiotic Essentials . Royal Oak, MI: Physicians’ Press; 2005;
  33. Sakoulas G , Eliopoulos GM , Alder J , Eliopoulos CT . Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother . 2003;47:1714–1718
  34. Cubist Pharmaceuticals . Daptomycin Package Insert . Lexington, MA: Cubist Pharmaceuticals; 2004;
  35. Dvorchik B . Moderate liver impairment has no influence on daptomycin pharmacokinetics . J Clin Pharmacol . 2004;44:715–722
  36. Veliglandla SR , Louie KR , Maleskar MA , Smith PW . Muscle pain associated with daptomycin . Ann Pharmacother . 2004;38:1860–1862

PII: S0147-9563(05)00258-X

doi: 10.1016/j.hrtlng.2005.09.010

Heart & Lung: The Journal of Acute and Critical Care
Volume 35, Issue 3 , Pages 207-211 , May 2006

Article Tools